Gilead’s sofosbuvir for hepatitis C meets primary endpoint in fourth pivotal Phase 3 study
19 February 2013 | By Gilead Sciences
Topline results from the Phase 3 FUSION study...
List view / Grid view
News
Sanofi New Drug Application for Lixisenatide accepted for review by FDA
19 February 2013 | By Sanofi
Sanofi announced that the U.S. FDA has accepted for review a New Drug Application for lixisenatide...
GSK and Theravance announce FDA acceptance of NDA submission in the US for ANORO ELLIPTATM for COPD
19 February 2013 | By GlaxoSmithKline
The NDA for the investigational once-daily LAMA/LABA combination medicine, UMEC/VI has been accepted...
Novartis drug Zortress® is first in over a decade approved by FDA to prevent organ rejection in adult liver transplant patients
15 February 2013 | By Novartis
The FDA has approved Zortress®...
ViiV Healthcare announces FDA priority review designation for dolutegravir as a potential treatment for HIV infection
15 February 2013 | By GlaxoSmithKline
The FDA has granted a priority review designation to dolutegravir...
Novo Nordisk launches NovoSeven® with pre-filled syringe for fast bleeding control
14 February 2013 | By Novo Nordisk
Novo Nordisk announced that NovoSeven® is now available...
Metrohm and FOSS enter strategic alliance
Metrohm and FOSS have entered into a strategic alliance strengthening the two companies’ leading positions in their respective key markets. In this strategic alliance, Metrohm will become the sole global distributor of FOSS NIR instruments for the chemical, petrochemical, pharmaceutical, and environmental sectors.
Daiichi Sankyo announces development of nucleic acid treatment for DMD utilizing proprietary technology
14 February 2013 | By Daiichi Sankyo
Daiichi Sankyo will establish a new company, Orphan Disease Treatment Institute Co., Ltd...
Bristol-Myers Squibb Appoints Ann Powell Judge Senior Vice President, Human Resources
14 February 2013 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb announced that Ann Powell Judge will join the company...
Teva announces FDA approval of generic Adderall XR®
14 February 2013 | By Teva Pharmaceutical Industries Ltd
TEVA announced that the U.S. FDA has approved its Abbreviated New Drug Application (ANDA)...
Tresiba® now ready to be launched in Japan
13 February 2013 | By Novo Nordisk
Novo Nordisk announced that it has received approval of the price of Tresiba® (insulin degludec)...
Bristol-Myers Squibb enters a collaboration agreement with Reckitt Benckiser Group plc
12 February 2013 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb has entered into an agreement with Reckitt Benckiser Group...
Teva Pharmaceuticals announces appointment of Dr. Arie Belldegrun to Board of Directors
11 February 2013 | By Teva Pharmaceutical Industries Ltd
Teva announced that Dr. Arie Belldegrun was appointed by the Board of Directors...
A microplate-based prion seeding assay is more sensitive and much faster than using animal models
11 February 2013 | By BMG LABTECH
Using a newly developed prion seeding assay researchers can now measure prion seeding...
Peter Rehse joins BioFocus as Senior Director, Structural Biology
11 February 2013 | By Zyme Communications
BioFocus announced that Dr. Peter Rehse has joined the company and will be based at Chesterford Park, near Cambridge, UK...
